Ecolab price target raised to $260 from $238 at RBC Capital

RBC Capital analyst Ashish Sabadra raised the firm’s price target on Ecolab to $260 from $238 and keeps an Outperform rating on the shares after its Q1 results and above-consensus guide. The company’s sales investments could sustain higher SG&A expenses while partially offsetting gross margin tailwinds and delivering robust operating margin expansion, the analyst tells investors in a research note. Ecolab’s Surgical Solutions’ divestiture should help improve focus on the company’s Healthcare business, RBC added.